Background Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by
the histopathological pattern of usual interstitial pneumonia and is associated with a high …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible lung disease of
unknown cause. It has been reported that both lung resident mesenchymal stem cells (LR …

An emerging paradigm proposes a crucial role for lung resident mesenchymal stem cells
(LR-MSCs) via a fibroblastic transdifferentiation event in the pathogenesis of idiopathic …

Idiopathic pulmonary fibrosis is a pathological result of dysfunctional repair response to
tissue injury, leading to chronically impaired gas exchange and death. Macrophages are …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal lung disease that is
characterized by enhanced changes in stem cell differentiation and fibroblast proliferation …

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease, but the
mechanisms driving progression remain incompletely defined. We previously reported that …

Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease with very
few effective treatments. The key effector cells in fibrosis are believed to be fibroblasts, which …

Idiopathic pulmonary fibrosis (IPF) is a major cause of respiratory failure in critically ill
patients and common outcome of various lung interstitial diseases. Its mortality remains …

Idiopathic pulmonary fibrosis is an inexorably progressive lung disease with few available
treatments. New therapeutic options are needed. Stem cells have generated much …

Lung-resident mesenchymal stem cells (LR-MSCs) are important regulators of lung repair
and regeneration, and evidence suggests that this cell population also plays a vital role in …